Skip to main content
. 2012 Jun 7;1(2):99–104. doi: 10.1159/000338920

Table 1.

Comparison of characteristics between cases and controls (matched for age, duration of follow-up and smoking habits) at baseline, 1 year prior to event and at the time of event in study A (de novo occurrence of TPO-Ab) and in study B (development of overt hypothyroidism)

Study A: development of TPO-Ab, 81 cases and 162 controls
baseline
1 year before event
at event
p value
cases controls cases controls cases controls baseline 1 year before event at event
TSH, mU/1 1.5 (1.2–2.2) 1.5 (1.1–1.9) 1.4 (1.1–2.2) 1.4 (1.0–1.9) 1.5 (1.1–2.2) 1.4 (1.0–2.0) 0.88 0.69 0.44
fT4, pmol/1 13.1 (11.6–14.5) 13.4 (12.0–14.9) 13.0 (11.7–14.4) 13.6 (12.1–14.8) 13.1 (11.9–14.5) 13.3 (12.0–14.3) 0.94 0.71 0.27
TPO-Ab, kU/1 <25 (<25–<25) <25 (<25–<25) <25 (<25–50) <25 (<25–50) 140 (110–160) <25 (<25–50) 0.48 0.45 <0.001
Tg-Ab, kU/1 15 (<10–25) <10 (<10–15) 18 (<10–35) <10 (<10–14) 17 (<10–43) <10 (<10–20) 0.19 0.01 0.01
Current smokers 38% 38% 31% 30% 31% 31% NS NS NS
Alcohol consumers* 14.5% 13.4% 14.1% 15.1% 11.3% 13.7% 0.82 0.84 0.60
Study B: development of overt hypothyroidism, 38 cases and 76 controls
baseline
1 year before event
at event
p value
cases controls cases controls cases controls baseline 1 year before event at event
TSH, mU/1 4.2 (2.7–5.7) 1.5 (1.1–2.5) 4.0 (2.6–6.1) 1.5 (0.9–2.4) 14.8 (6.3–16.9) 1.5 (1.0–2.4) 0.06 0.03 0.005
fT4, pmol/1 10.7 (9.7–11.6) 13.0 (11.3–15.1) 10.6 (9.5–12.0) 13.4 (11.9–14.3) 7.1 (4.8–8.4) 13.0 (11.5–14.5) 0.38 0.17 0.02
TPO-Ab, kU/1 1,123 (304–2,239) <25 (<25–150) 1,076 (666–2,326) 50 (<25–320) 3,000 (1,620–6,670) <25 (<25–180) 0.004 0.008 <0.001
Tg-Ab, kU/1 75 (40–238) 15 (<5–40) 123 (42–235) 15 (<10–40) 140 (100–500) 10 (<10–50) 0.03 0.02 0.001
Current smokers 18% 18% 18% 18% 13% 13% NS NS NS
Alcohol consumers* 8.3% 14.5% 5.3% 19.7% 6.7% 23.7% 0.36 0.04 0.04
*

>10 units/week. Data given as median (interquartile range).